HGH - The Amazing New Cancer Support Treatment Does HGH cure cancer? Absolutely not. Cancer is a complex disease that must be addressed from every angle possible, medically, naturopathically, nutritionally, psychologically and spiritually. No one single modality by itself seems to be enough to overcome this condition. According to the National Cancer Institute, two thirds of people who die from cancer actually die from cachexia, the lean tissue wasting that starts with the muscles and support tissue and progresses to the vital organs. One of the benefits of HGH therapy is that it not only prevents lean tissue wasting, it actually builds lean tissue which is exactly what the cancer patient needs. Another feature of cancer patients is that they are generally hypopituitary and are often extremely low in serum IGF-1, the blood test which determines HGH levels. The primary purpose of HGH therapy, of course, is to address hypopituitarism. The possibility of stimulating tumor growth or somehow feeding the cancer through HGH therapy had been a concern for many doctors until October 1999 when the New England Journal of Medicine concluded that "There is no evidence that Growth Hormone Replacement Therapy increases or affects the risk of cancer." Furthermore, in February 2002 after thousands more patient years of research the Journal of Clinical Endocrinology & Metabolism reported that "Although there has been some concern in the medical community about the possible increased risk of cancer associated with taking the human growth hormone, an extensive review of well maintained data bases of treated patients has shown this theoretical risk now non-existent." In April 1997 the Medical Journal of Endocrinology reported that "HGH therapy resulted in thymic gland involution and repair of both T cells and B cells." The Journal went on to say that "HGH was needed for healthy lymphatic maturity and function" and that "age-associated loss of bone marrow could be restored with HGH." Cancer patients need a recharged immune system and they also need to rebuild strong lean tissue; this is exactly what HGH restoration therapy does as Dr. Rudman demonstrated in the New England Journal of Medicine in July 1990. The biggest fear with HGH therapy and cancer has always been with prostate cancer in men. In August 1998 the Science Journal reported on the research findings of Dr. Shaffer who had studied 785 men on HGH therapy. He declared that "There is no association with growth hormone replacement therapy and prostate cancer." In fact, the highest incidence of prostate cancer was found in men with the lowest level of HGH and the lowest level of cancer was found in men with the highest IGF-1 blood levels. In short, HGH is not only not a contributor to the risk of cancer, according to the latest scientific research it is a natural protector against cancer and an enhancer of the entire immune system. The theoretical risk of feeding a cancer with HGH therapy never made any sense to begin with. Now that it has been demonstrated scientifically not only to be safe but, also, beneficial for cancer patients HGH restoration therapy must be considered as part of a total cancer support protocol.